These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 7930614

  • 1. Topology of the loxoribine binding site. Studies with inactive loxoribine analogues.
    Goodman MG, Goodman JH.
    J Immunol; 1994 Nov 01; 153(9):4081-7. PubMed ID: 7930614
    [Abstract] [Full Text] [Related]

  • 2. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
    Pope BL, Chourmouzis E, MacIntyre JP, Lee S, Goodman MG.
    Cell Immunol; 1994 Dec 01; 159(2):194-210. PubMed ID: 7994754
    [Abstract] [Full Text] [Related]

  • 3. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL, Chourmouzis E, Sigindere J, MacIntyre JP, Capetola RJ, Lau CY.
    Cell Immunol; 1993 Apr 01; 147(2):302-12. PubMed ID: 8453674
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.
    Pope BL, Chourmouzis E, Victorino L, MacIntyre JP, Capetola RJ, Lau CY.
    J Immunol; 1993 Sep 15; 151(6):3007-17. PubMed ID: 8376766
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhancement of immunostimulatory activity by dual substitution of C8-substituted guanine ribonucleosides: correlation with increased cytokine secretion.
    Pope BL, Chourmouzis E, Lee S, Goodman MG.
    J Immunother Emphasis Tumor Immunol; 1995 Feb 15; 17(2):98-108. PubMed ID: 7647961
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dissociation of inductive from differentiative signals transmitted by C8-substituted guanine ribonucleosides to B cells from SJL mice.
    Goodman MG, Weigle WO.
    J Immunol; 1985 Jan 15; 134(1):91-4. PubMed ID: 3871118
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Proliferation of spleen cells in culture stimulated by 7-thia-8-oxoguanosine: evidence that both B- and T-cells are the targets of its action.
    Colic M, Vucevic D, Vasilijic S, Popovic L, Pejanovic V, Jandric D, Medic-Mijacevic L, Rakic L.
    Methods Find Exp Clin Pharmacol; 1999 Nov 15; 21(9):583-90. PubMed ID: 10669901
    [Abstract] [Full Text] [Related]

  • 15. B lymphocytes from hyporesponsive SJL mice contain aberrant nucleoside binding sites.
    Goodman MG.
    Cell Immunol; 1990 Sep 15; 129(2):377-84. PubMed ID: 2383897
    [Abstract] [Full Text] [Related]

  • 16. A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity.
    Peng LS, Penichet ML, Morrison SL.
    J Immunol; 1999 Jul 01; 163(1):250-8. PubMed ID: 10384123
    [Abstract] [Full Text] [Related]

  • 17. Induction of immunoglobulin secretion by a simple nucleoside derivative.
    Goodman MG, Weigle WO.
    J Immunol; 1982 Jun 01; 128(6):2399-404. PubMed ID: 6281331
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of acyl residues in polyclonal murine B cell activation by acylpoly(1,3)galactosides from Klebsiella pneumoniae.
    Hmama Z, Lina G, Normier G, Binz H, Revillard JP.
    J Immunol; 1993 Nov 15; 151(10):5440-9. PubMed ID: 8228237
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.